Mr Tracy Lee Mcmonigle, PA-C /MPAS | |
Us Naval Hospital Guam, Farenholt Ave Bldg K-1, Agana Hts, GU 96919 | |
(671) 344-9619 | |
Not Available |
Full Name | Mr Tracy Lee Mcmonigle |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | Us Naval Hospital Guam, Agana Hts, Guam |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366422396 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Tracy Lee Mcmonigle, PA-C /MPAS Us Naval Hospital Guam, Farenholt Ave Bldg K-1, Agana Hts, GU 96919 Ph: (671) 344-9619 | Mr Tracy Lee Mcmonigle, PA-C /MPAS Us Naval Hospital Guam, Farenholt Ave Bldg K-1, Agana Hts, GU 96919 Ph: (671) 344-9619 |
News Archive
Between 2005 and 2015, as the opioid crisis in America came into focus, prescriptions for gabapentinoid medications - gabapentin and pregabalin - to adults with cancer saw a two-fold increase, a University of Michigan Rogel Cancer Center study has found.
The Washington Post: "Former Senate majority leader Thomas A. Daschle's visit to the Oval Office on Friday, at the invitation of President Obama, was more than just a meeting between two loyal friends and political allies. It also served as a reminder of what might have been."
Diabetes affects more than 400 million people worldwide and is a major public health problem. Although commonly referred to as a single disease, it actually constitutes a group of metabolic disorders with hyperglycemia as a common feature. Of all its forms, monogenic diabetes - due to a mutation in one of the genes involved in the management of blood sugar levels - affects 1% to 4% of all cases of diabetes.
Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
› Verified 8 days ago